MYRIAD GENETICS INC — Director's Dealing 2023

Sep 27, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2023-09-26

Reporting Person: Riggsbee Richard Bryan (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-26	Common Stock	F	4517	$15.99	Disposed	364148	Direct

Footnotes

F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2023.